Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
|
|
Juno Therapeutics, Inc. (JUNO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/05/2018 |
SC 13D/A
| CELGENE CORP reports a 85.4% stake in JUNO THERAPEUTICS, INC. |
| 02/22/2018 |
SC 13D/A
| CELGENE CORP reports a 9.7% stake in JUNO THERAPEUTICS, INC. |
| 02/21/2018 |
SC 13D/A
| CELGENE CORP reports a 9.7% stake in JUNO THERAPEUTICS, INC. |
| 02/14/2018 |
SC 13D/A
| CELGENE CORP reports a 9.7% stake in JUNO THERAPEUTICS, INC. |
| 02/07/2018 |
SC 13D/A
| BRATTON DOUGLAS K reports a 4.7% stake in Juno Therapeutics, Inc. |
| 02/02/2018 |
SC 13D/A
| CELGENE CORP reports a 9.7% stake in JUNO THERAPEUTICS, INC. |
| 01/22/2018 |
SC 13D/A
| CELGENE CORP reports a 9.7% stake in Juno Therapeutics, Inc. |
| 11/08/2017 |
SC 13D/A
| BRATTON DOUGLAS K reports a 6.7% stake in Juno Therapeutics, Inc. |
| 09/26/2017 |
SC 13D/A
| Celgene Switzerland LLC reports a 9.7% stake in Juno Therapeutics, Inc. |
| 07/17/2017 |
SC 13D/A
| BRATTON DOUGLAS K reports a 8.8% stake in Juno Therapeutics, Inc. |
| 03/27/2017 |
SC 13D/A
| Celgene Switzerland LLC reports a 9.7% stake in Juno Therapeutics, Inc. |
| 03/29/2016 |
SC 13D/A
| Celgene Switzerland LLC reports a 9.7% stake in Juno Therapeutics, Inc. |
|
|